Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580268 · ClinicalTrials.gov registry record
Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity
A clinical trial of Bipolar Disorder and Psychiatric Morbidity, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 118
- Enrollment target
- 2
- Study locations
NCT00580268 is a study of Bipolar Disorder and Psychiatric Morbidity that has completed, run by Massachusetts General Hospital. The registered enrollment target is 118 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00580268, a study of Bipolar Disorder and Psychiatric Morbidity, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to examine risk factors for relapse of bipolar disorder during pregnancy and the postpartum period. The main goal of this study is to find the risks that may make it more likely for a woman with bipolar disorder to experience a depressive, manic, or hypomanic episode during her pregnancy and the postpartum period.
Conditions Studied
Study Locations (2)
Georgia
- Emory University - Atlanta
Massachusetts
- Massachusetts Geral Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2005-08 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580268
The ClinicalTrials.gov registry entry for NCT00580268 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT00580268 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00580268 about?
NCT00580268 is a clinical study titled "Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity". The purpose of this study is to examine risk factors for relapse of bipolar disorder during pregnancy and the postpartum period. The main goal of this study is to find the risks that may make it more likely for a woman with bipolar disorder to experience a depressive, manic, or hypomanic episode dur...
What is the current status of trial NCT00580268?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2005-08. Estimated completion is 2013-07.
What conditions does trial NCT00580268 study?
This clinical trial studies the following conditions: Bipolar Disorder, Psychiatric Morbidity, Neonatal Outcome.
Who is sponsoring clinical trial NCT00580268?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00580268 being conducted?
This trial has 2 study locations across Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.